Skip to main content
. Author manuscript; available in PMC: 2013 Aug 7.
Published in final edited form as: Int J Tuberc Lung Dis. 2012 Jun;16(6):724–732. doi: 10.5588/ijtld.12.0083

Figure 1.

Figure 1

EBA during the first 2 days of treatment with a range of dose sizes of INH, RMP or SM chosen to include low doses that produced no EBA. EBA = early bactericidal activity; INH = isoniazid; RMP = rifampicin; SM = streptomycin.